Use of friedewald equation for dyslipidemia in metabolic syndrome

  • Authors

    • Jaspinder Kaur ECHS Polyclinic
    2014-05-12
    https://doi.org/10.14419/ijm.v2i1.2370
  • Objective: The Friedewald equation is frequently used to estimate low-density lipoprotein cholesterol (LDL-C) in routine patient care; however, recently many limitations have emerged regarding its use.

    Aim: Analyse the use of Friedewald equation for dyslipidemia in metabolic syndrome.

    Methods: Subjects were selected with metabolic syndrome that fulfilled consensus statement for Asians Indians and excluded those with triglyceride (TG) ?400mg/dl, and chronic liver and/or kidney disease. Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), TGs, and LDL-C were measured with direct assays. LDL-C was further estimated using the equation and compared with LDL-C by direct assay.

    Results: The mean and standard deviation of TC, TGs, HDL-C, and LDL-C were 194.77±24.38mg/dl, 174.84±60.27mg/dl (p<0.0001), 40.68±5.40mg/dl (p<0.05), and 122.30±19.30mg/dl among subjects with metabolic syndrome. On the other hand, Friedewald estimated LDL-C and VLDL-C were 121.29±18.84mg/dl and 35.08±12.65mg/dl (p<0.0001). Furthermore, a statistically significant higher TGs/HDL-C (p<0.0001) and LDL-C/HDL-C ratios was observed in subjects with metabolic syndrome. However, no significant difference was recorded between the two methods of estimating LDL-C.

    Conclusion: TGs/HDL-C was found significantly higher among subjects with metabolic syndrome; however, no significant difference between both Friedewald equation and direct measurement method for LDL-C estimation was observed. Hence, the accuracy of LDL-C estimation formulas and direct methods for measurement in patients with the metabolic syndrome requires further exploration.

     

    Keywords: Dyslipidemia, Friedewald Equation, Metabolic Syndrome.

  • References

    1. Bairaktari ET, Tzallas C, Kalientzidou M, Tselepis AD, Si-amopoulos KC, Seferiadis KI & Elisaf M (2004) Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patients. Clinical Bio-chemistry 37, 937-940.
    2. Bittner V, Johnson BD, Zineh I, Rogers WJ, Vido D, Marroquin OC, Bairey-Merz CN & Sopko G (2009) The TG/HDL Cholesterol Ratio Predicts All-Cause Mortality in Women With Suspected Myocardial Ischemia A Report from the Women’s Ischemia Syndrome Evaluation (WISE). American Heart Journal 157, 548–555.
    3. Charuruks N & Milintagas A (2005) Evaluation of calculated low density lipoprotein against a direct assay. Journal of the Medical Association of Thailand 88, S274-S279.
    4. Da luz PL, Cesena FH, Favarato D & Cerqueira ES (2005) Comparison of serum lipid values in patients with coronary artery disease at <50, 50 to 59, 60 to 69, and >70 years of age. American Journal of Cardiology 96, 1640-3.
    5. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18, 499–502.
    6. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S, Gupta M, Hegele RA, Lau DC, Leiter L, Lewis GF, Lonn E, Mancini GBJ, Ng D, Pearson GJ, Sniderman A, Stone JA & Ehud Ur (2009) Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult. Canadian Journal of Cardiology 25, 567–79.
    7. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr., Clark LT Hunninghake DB Pasternak RC, Smith SC Jr, & Stone NJ (2004) National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the national cholesterol education program adult Treatment Panel III guidelines. Circulation 110, 227-39.
    8. Hirany S, Li D & Jialal I (1997) A more valid measurement of low-density lipoprotein cholesterol in diabetic patients. The American Journal of Medicine 102, 48–53.
    9. Jeppesen J, Hein HO, Suadicani P & Gyntelberg F (1998) Triglycerides concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97, 1029-36.
    10. Jun KR, Park HI, Chun S, Park H & Min WK (2008) Effects of total cholesterol and triglyceride on the percentage difference between the LDL-C concentrations measured directly and calculated using the Friedewald formula. Clinical Chemistry and Laboratory Medicine 46, 371–5.
    11. Kaur J (2014) A comprehensive review of metabolic syndrome. Cardiology Research and Practice Article ID 943162, 1-21.
    12. Knopfholz J, Disserol CCD, Pierin AJ, Schirr FL, Streisky L, Takito LL, Ledesma PM, Faria-Neto JR, Olandoski M, Cunha CLPD & Bandeira AM (2014) Validation of the Friedewald Formula in Patients with Metabolic Syndrome. Cholesterol Ar-ticle ID 261878, 1-5.
    13. Luz PLD, Favarato ID, Faria-Neto IJR Jr., Lemos P & Chagas IACP (2008) High ratio of triglycerides to hdl-cholesterol predicts extensive coronary disease. Clinics 64, 427-32.
    14. Martin SS, Blaha MJ, Elshazly MB, Brinton EA, Toth PP, McEvoy JW, Joshi PH, Kulkarni KR, Mize PD, Kwiterovich PO, DeFilippis AP, Blumenthal RS & Jones SR (2013) Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications. Journal of the American College of Cardiology 62, 732–9.
    15. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, Joshi SR, Sadikot S, Gupta R, Gulati S, Munjal YP & Concensus Group (2009) Consensus statement for diagnosis of obesity, abdominal obesity and the Metabolic Syndrome for Asian Indians and Recommendations for Physical activity, medical and surgical management. Journal of Association of Physicians of India 57, 163–170.
    16. Piva JPJ & Fernandes TRL (2008) Comparac¸˜ao anal´ıtica de valores de LDL-colesterol utilizando a dosagem direta e o c´alculo pela f´ormula de Friedewald. Revista Brasileira de An´alises Cl´ınicas 40, 279–283.
    17. Puavilai W, Laorugpongse D, Deerochanawong C, Muthapongthavorn N & Srilert P (2009) The Accuracy in Using Modified Friedewald Equation to Calculate LDL from Non-Fast Triglyceride: A Pilot Study. Journal of the Medical Association of Thailand 92, 182-7.
    18. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, Bax J, Vahanian A, Auricchio A, et al. (2011) ESC/EAS guidelines for the management of dyslipi-daemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Heart Journal 32, 1769–818.
    19. Robinson JG, Smith B, Maheshwari N & Schrott H (2005) Pleiotropic effects of statins: Benefit beyond cholesterol reduc-tion? A meta-regression analysis. Journal of the American col-lege of cardiology 46, 1855-62.
    20. Sahu S, Chawla R & Uppal B (2005) Comparison of two methods of estimation of low density lipoprotein cholesterol, the direct versus friedewald estimation. Indian Journal of Clinical Biochemistry 20, 54-61.
    21. Smith SC Jr., Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein JH & Taubert KA (2011) AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. Journal of the American college of cardiology 58, 2432–46.
    22. Whiting MJ, Shephard MDS & Tallis GA (1997) Measurement of Plasma LDL Cholesterol in Patients with Diabetes. Diabetes Care 20, 12-14.
    23. Yu HH, Markowitz R, De Ferranti SD, Neufeld EJ, Farrow G, Bernstein HH & Rifai N (2000) Direct measurement of LDL-C in children: Performance of two surfactant-based methods in a general pediatric population. Clinical Biochemistry 33, 89-95.
  • Downloads

  • How to Cite

    Kaur, J. (2014). Use of friedewald equation for dyslipidemia in metabolic syndrome. International Journal of Medicine, 2(1), 36-39. https://doi.org/10.14419/ijm.v2i1.2370